Therese Choquette
CTO, Tigen Pharma
Therese Choquette is listed as CTO, Tigen Pharma. Therese is scheduled to speak at Advanced Therapies Week 2027 on 20 January 2027.
Compiled from published conference agendas; not yet confirmed by Therese. Is this you? Claim this profile.
About
Therese Choquette is the Chief Technical Officer at Tigen Pharma (Lausanne, Switzerland) She has a long-standing experience in Cell & Gene Therapy, analytical development and CMC; from early development into the commercial space. Therese obtained a MSc in Biomedicine and PhD in Rheumatology from the Karolinska Institute in Stockholm, Sweden.
Upcoming
Advanced Therapies Week 2027 19 January 2027 – 21 January 2027
- Panel discussion Speaker · 20 January 2027
- Session 6: Cell therapy product characterization and QC Speaker · 20 January 2027
Spoke alongside
People who have shared a session with Therese at events on B2DB.
- Damian Marshall VP - Analytical Development · Resolution Therapeutics 2 shared sessions
- Erin Cross Vice President of Development · KROMATID 2 shared sessions
- Nolan Polson Vice President, Quality Assurance & Product Quality · Iovance Biotherapeutics, Inc. 2 shared sessions
- Alejandra Gutierrez Guerrero Product Manager, Cell Therapy Biomaterial · Grifols Bio Supplies 1 shared session
- Steven Falcone COO · Elevatebio 1 shared session